Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.1K
Overview
45.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

116
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
116

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DepoCatalog: mapping diversity of 129 recombinantly produced Klebsiella phage depolymerases.

Nature communications·2026
Same author

Mycobacterial fusion protein REA eliciting anti-tumor activity through activation of innate immunity.

International immunopharmacology·2026
Same author

Structural and binding studies of the mycobacterial heat shock protein reveal a silent state and offer insights into dendritic cell activation.

International journal of biological macromolecules·2026
Same author

AI-Driven Structural Elucidation of the Bacteriophage KP32: Decoding Its Molecular Arsenal Against <i>Klebsiella Pneumoniae</i>.

Frontiers in bioscience (Landmark edition)·2025
Same author

IFN-γ and IL-17 elicit synergistic anti-mycobacterial responses by inhibiting coronin-1A retention.

Communications biology·2025
Same author

Dual-Function Plant-Derived Nanovesicles From Regenerated Cannabis sativa Roots for Immunotherapy and Vaccine Delivery.

Journal of extracellular vesicles·2025

Related Experiment Video

Updated: Aug 13, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.1K

A Structural View at Vaccine Development against M. tuberculosis.

Maria Romano1,2, Flavia Squeglia1, Eliza Kramarska1

  • 1Institute of Biostructures and Bioimaging, IBB, CNR, 80131 Naples, Italy.

Cells
|January 21, 2023
PubMed
Summary

Developing new tuberculosis (TB) vaccines is crucial due to the ineffectiveness of the current BCG vaccine. Structural Vaccinology (SV) advances safer, effective subunit vaccines by improving antigen design and understanding immune responses.

Keywords:
immune responseproteinstructuretuberculosisvaccine

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

9.5K

Related Experiment Videos

Last Updated: Aug 13, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.1K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

9.5K

Area of Science:

  • * Infectious disease epidemiology and vaccinology.
  • * Application of structural biology and immunology in vaccine development.

Background:

  • * Tuberculosis (TB) remains a leading cause of death from infectious bacterial agents globally.
  • * The existing Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine, used since 1921, offers insufficient protection, necessitating novel vaccine strategies.
  • * Despite decades without new vaccines, TB research has accelerated due to technological advancements and rational vaccine design.

Purpose of the Study:

  • * To review recent progress in TB vaccine development across various clinical phases.
  • * To highlight the role of Structural Vaccinology (SV) in creating safer and more effective TB vaccine antigens.
  • * To emphasize the potential of subunit vaccines, enhanced by SV and adjuvants, for improved TB control.

Main Methods:

  • * Comprehensive literature review of current TB vaccine research and clinical trials.
  • * Analysis of the contribution of Structural Vaccinology (SV) to antigen design and understanding immune responses.
  • * Evaluation of strategies for re-engineering subunit vaccines to enhance immunogenicity.

Main Results:

  • * Structural Vaccinology (SV) facilitates the development of safer subunit vaccines by providing detailed antigen structural information.
  • * SV, combined with adjuvant development, addresses the challenge of low immunogenicity in subunit vaccines.
  • * Advances in understanding host immune responses to TB infection are crucial for rational vaccine design.

Conclusions:

  • * Novel TB vaccines are urgently needed, with subunit vaccines offering a promising, safer alternative to BCG.
  • * Structural Vaccinology (SV) is pivotal in re-engineering subunit vaccines for enhanced efficacy.
  • * Continued research integrating SV, adjuvant technology, and immune response understanding will accelerate the development of effective TB vaccines.